Patent details

EP2318028 Title: ANTAGONISTS OF SOLUBLE ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS

Basic Information

Publication number:
EP2318028
PCT Application Number:
US2009003838
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP097705719
PCT Publication Number:
WO2009158033
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTAGONISTS OF SOLUBLE ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS
French Title of Invention:
ANTAGONISTES SOLUBLES D'ACTIVINE-ACTRIIA ET UTILISATIONS POUR AUGMENTER LES TAUX D'ÉRYTHROCYTES
German Title of Invention:
ANTAGONISTEN VON LÖSLICHEM ACTIVIN-ACTRIIA UND VERWENDUNGEN ZUR ERHÖHUNG DER ANZAHL ROTER BLUTKÖRPERCHEN
SPC Number:

Dates

Filing date:
26/06/2009
Grant date:
19/02/2020
EP Publication Date:
11/05/2011
PCT Publication Date:
30/12/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/02/2020
EP B1 Publication Date:
19/02/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
26/06/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/02/2020
 
 

Name:
Acceleron Pharma Inc.
Address:
128 Sidney Street, Cambridge, MA 02139, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
09/04/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
BORGSTEIN, Niels
Address:
United States (US)

2

Name:
SEEHRA, Jasbir
Address:
United States (US)

3

Name:
SHERMAN, Matthew, L.
Address:
United States (US)

Priority

Priority Number:
133368 P
Priority Date:
26/06/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/17; A61P 7/06; A61K 47/68;

Publication

European Patent Bulletin

Issue number:
202008
Publication date:
19/02/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/06/2026
Annual Fee Number:
18
Annual Fee Amount:
262 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/05/2025
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
09/04/2020 Outgoing Correspondence 1
09/04/2020 Power Of Attorney 1